Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
50.5M
-
Number of holders
-
267
-
Total 13F shares, excl. options
-
34.4M
-
Shares change
-
+865K
-
Total reported value, excl. options
-
$1.38B
-
Value change
-
+$32.8M
-
Put/Call ratio
-
0.97
-
Number of buys
-
136
-
Number of sells
-
-133
-
Price
-
$40.00
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q2 2024
310 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q2 2024.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 267 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.4M shares
of 50.5M outstanding shares and own 68.12% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.94M shares), VANGUARD GROUP INC (2.67M shares), FEDERATED HERMES, INC. (1.94M shares), TD Asset Management Inc (1.69M shares), NEUBERGER BERMAN GROUP LLC (1.62M shares), STATE STREET CORP (1.53M shares), FULLER & THALER ASSET MANAGEMENT, INC. (1.27M shares), Epoch Investment Partners, Inc. (1.08M shares), DIMENSIONAL FUND ADVISORS LP (1.07M shares), and GEODE CAPITAL MANAGEMENT, LLC (906K shares).
This table shows the top 267 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.